Metabolic modulators in cardioprotection: A focus on trimetazidine
Cardiovascular diseases remain a significant health burden worldwide, necessitating the development of effective cardioprotective strategies. Central to this pursuit is the recognition of metabolic dysregulation as a key contributor to the pathogenesis of cardiovascular diseases, particularly in the...
Saved in:
Main Author: | Du Qingyou (Author) |
---|---|
Format: | Book |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nicotinamide: A cardioprotective form of Vitamin B3
by: Du Qingyou
Published: (2024) -
Trimetazidine in Heart Failure
by: Hongyang Shu, et al.
Published: (2021) -
Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
by: Hongyang Shu, et al.
Published: (2021) -
METABOLIC CARDIOPROTECTION: NEW CONCEPTS IN IMPLEMENTATION OF CARDIOPROTECTIVE EFFECTS OF MELDONIUM
by: Lyudmila Danilenko, et al.
Published: (2016) -
Trimetazidine Modulates Mitochondrial Redox Status and Disrupted Glutamate Homeostasis in a Rat Model of Epilepsy
by: Muhammad Y. Al-Shorbagy, et al.
Published: (2021)